Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy is a research paper published in Advances in cancer research (2023). On theSindex it has a DataRank of 0.663. It has been cited 15 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.247
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
National Cancer Institute
Grant: R01 CA244993
National Cancer Institute
Grant: R01 CA259599
NCI NIH HHS
Grant: P30 CA016059
National Institutes of Health
National Foundation for Cancer Research
Institute of Molecular Medicine, School of Medicine, Shanghai Jiao Tong University
Virginia Commonwealth University
FWCI
14.61
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals